The paradox of indolent non-Hodgkin lymphoma (NHL) is that while the protracted nature of the disease and treatment responsiveness allow for extended survival, advanced-stage disease remains incurable, which requires patients to be managed over a lifetime. In addition, although outcome is favorable
No takes yet. Share an insight, caveat, or question.
L. H. Sehn (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: